Single-center study of 72 patients with severe combined immunodeficiency: clinical and laboratory features and outcomes

dc.authoridFunda Erol Çipe / 0000-0002-9718-7507
dc.authorscopusidFunda Erol Çipe / 25824763200
dc.authorwosidFunda Erol Çipe / GDE-8701-2022
dc.contributor.authorBayram, Özlem
dc.contributor.authorHaskolo?lu, Şule
dc.contributor.authorBayrakoğlu, Deniz
dc.contributor.authorBal, Sevgi Köstel
dc.contributor.authorİslamoğlu, Candan
dc.contributor.authorErol Çipe, Funda
dc.contributor.authorKendirli, Tanıl
dc.contributor.authorKurşun, Nazmiye
dc.date.accessioned2021-06-21T08:46:38Z
dc.date.available2021-06-21T08:46:38Z
dc.date.issued2021en_US
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractAbstract: Severe combined immunodeficiency is an inborn error of immunity characterized by impairments in the numbers and functions of T and B lymphocytes due to various genetic causes, and if it remains untreated, patients succumb to infections during the first 2 years of life. Purpose and Methods: This study reported retrospective data from 72 infants diagnosed with SCID including their major clinical features, HSCT characteristics, and outcomes over a 20-year period (1997–2017). Results: Sixty-one of 72 SCID patients in the study underwent HSCT from 1997 to 2017. Median ages at the time of diagnosis and transplantation were 3.5 months and 5 months, respectively. Consanguinity was present in 68% of the patients, and T ? B ? NK + phenotype was predominantly identified. The overall survival was 80.3% over a 20-year period. However, the patients transplanted during an active infection had a lower survival rate of 73.9% compared to 100% for patients transplanted infection-free or with a previous infection that had resolved. The survival rate was significantly higher among recipients of HLA-identical transplants (92.9%), compared to recipients of mismatched related transplants (70%). The overall survival increased from 50 (1997–2006) to 85% (2007–2017) during the last 10 years. Conclusions: This is one of the largest single-center studies in Turkey with extensive experience about SCID patients. Early diagnosis of SCID patients before the onset of an infection and early transplantation are shown to be extremely important factors affecting the outcome and increasing the survival regardless of the donor type based on the results of this study.en_US
dc.identifier.citationBayram, O., Haskologlu, S., Bayrakoğlu, D., Bal, S. K., Islamoglu, C., Cipe, F. E., ... & Ikinciogullari, A. (2021). Single-Center Study of 72 Patients with Severe Combined Immunodeficiency: Clinical and Laboratory Features and Outcomes. Journal of Clinical Immunology, 1-11.en_US
dc.identifier.doi10.1007/s10875-021-01062-yen_US
dc.identifier.issn0271-9142en_US
dc.identifier.pmid34114123en_US
dc.identifier.scopus2-s2.0-85107734495en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1007/s10875-021-01062-y
dc.identifier.urihttps://hdl.handle.net/20.500.12713/1809
dc.identifier.wosWOS:000659780700002en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorErol Çipe, Funda
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofJournal of Clinical Immunologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectClinical Featuresen_US
dc.subjectHematopoietic Stem Cell Transplantaion (HSCT)en_US
dc.subjectOutcomesen_US
dc.subjectSevere Combined Immunodeficiency (SCID)en_US
dc.titleSingle-center study of 72 patients with severe combined immunodeficiency: clinical and laboratory features and outcomesen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
79.pdf
Boyut:
593.95 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: